Our new anti-malaria ostaa nitrofurantoin ilman rx drug, likely the first from India, will benefit patients immensely and provide more potent solution to developing nations where malaria is endemic, Chairman CEO and MD Malvinder Mohan Singh said. Report of Intermediate indicates that the result should be considered equivocal, and, if the microorganism is not fully susceptible to alternative, clinically feasible drugs, the test should be repeated. The broad-based nature of this mode of action may explain the lack of acquired bacterial resistance to nitrofurantoin, as the necessary multiple and simultaneous mutations of the target macromolecules would likely be lethal to the bacteria. Sales in North America, Ranbaxy biggest market, shrank by seven percent in the first quarter. Always seek the advice of qualified health provider with any questions you may have before making any changes to your treatment.